Ekene Onwuka

ORCID: 0000-0003-2970-9120
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tissue Engineering and Regenerative Medicine
  • Electrospun Nanofibers in Biomedical Applications
  • Tracheal and airway disorders
  • Sarcoma Diagnosis and Treatment
  • Airway Management and Intubation Techniques
  • Congenital Heart Disease Studies
  • Intestinal Malrotation and Obstruction Disorders
  • Appendicitis Diagnosis and Management
  • Esophageal and GI Pathology
  • Vascular Tumors and Angiosarcomas
  • Dysphagia Assessment and Management
  • Congenital gastrointestinal and neural anomalies
  • Colorectal Cancer Surgical Treatments
  • Global Health and Surgery
  • Diversity and Career in Medicine
  • Global Health Workforce Issues
  • Cardiac, Anesthesia and Surgical Outcomes
  • Body Contouring and Surgery
  • Thyroid and Parathyroid Surgery
  • Cardiac Fibrosis and Remodeling
  • Head and Neck Anomalies
  • Obstructive Sleep Apnea Research
  • Ear and Head Tumors
  • Foreign Body Medical Cases
  • Educational Robotics and Engineering

Texas Children's Hospital
2022-2025

Baylor College of Medicine
2022-2025

Children's Cancer Center
2025

Nationwide Children's Hospital
2015-2020

The Ohio State University
2015-2020

The Ohio State University Wexner Medical Center
2015-2020

Howard University
2011

We developed a tissue-engineered vascular graft (TEVG) for use in children and present results of U.S. Food Drug Administration (FDA)-approved clinical trial evaluating this patients with single-ventricle cardiac anomalies. The TEVG was used as Fontan conduit to connect the inferior vena cava pulmonary artery, but high incidence narrowing manifested within first 6 months, which treated successfully angioplasty. To elucidate mechanisms underlying early stenosis, we data-informed,...

10.1126/scitranslmed.aax6919 article EN Science Translational Medicine 2020-04-01

ABSTRACT Background Wilms tumor (WT) is the most common pediatric malignancy of kidney. Past studies describing WT incidence and survival used surveillance data with < 30% US population. We evaluated differences in comparing demographic groups characteristics. Methods analyzed new cases among patients aged 20 years at diagnosis by using from Cancer Statistics (USCS) for 2003–2020 5‐year relative (RS) National Program Registries (NPCR) 2001–2019. To assess trends, average annual percent...

10.1002/cam4.70598 article EN cc-by Cancer Medicine 2025-02-01

Humans receiving tissue-engineered tracheal grafts have experienced poor outcomes ultimately resulting in death or the need for graft explantation. We assessed performance of synthetic scaffolds used humans with an ovine model orthotopic replacement, applying standard postsurgical surveillance and interventions to define factors that contributed complications seen at bedside.Large animal model.Pediatric academic research institute.Human were manufactured electrospun blend polyethylene...

10.1177/0194599819844754 article EN Otolaryngology 2019-04-30

There appears to be an increasing acceptance of cosmetic surgery procedures among minority populations in America. Our objective was determine trends elective procedure utilization as they apply racial/ethnic differences. A retrospective analysis performed using the Nationwide Inpatient Sample. Adult patients undergoing defined by appropriate International Classification Disease 9 Clinical Modification codes were included. Demographic characteristics and hospital course particulars...

10.1177/000313481107700832 article EN The American Surgeon 2011-08-01

Aim: This study evaluates scaffold degradation and neotissue formation as a function of sealant polymer composition in tissue-engineered vascular grafts (TEVGs). Materials & methods: Scaffolds fabricated from polyglycolic acid core composed polycaprolactone (PCL), poly-L-lactic-acid (PLLA) or 50:50 copolymer poly(ε-caprolactone-co-L-lactide) (PCLA) were analyzed vitro using accelerated scanning electron microscopy, vivo following implantation murine inferior vena cava interposition model....

10.2217/rme-2018-0069 article EN Regenerative Medicine 2019-07-01

Aim: Inflammatory myeloid lineage cells mediate neotissue formation in tissue-engineered vascular grafts, but the molecular mechanism is not completely understood. We examined role of vasculogenic PDGF-B graft development. Materials & methods: Myeloid cell-specific knockout mice (PDGF-KO) were generated using bone marrow transplantation, and scaffolds implanted as inferior vena cava interposition grafts either PDGF-KO or wild-type mice. Results: After 2 weeks, from had more remaining...

10.2217/rme-2016-0141 article EN Regenerative Medicine 2017-04-01

Objective To evaluate the safety and efficacy of bronchoscopic interventions in management tissue‐engineered tracheal graft (TETG) stenosis. Study Design Animal research study. Methods TETGs were constructed with seeded autologous bone marrow‐derived mononuclear cells on a bioartificial graft. Eight sheep underwent resection orthotopic implantation this construct. Animals monitored by bronchoscopy fluoroscopy at 3 weeks, 6 months, 4 months. Bronchoscopic interventions, including dilation...

10.1002/lary.26504 article EN The Laryngoscope 2017-03-27

Current techniques for airway characterization include endoscopic or radiographic measurements that produce static, two-dimensional descriptions. As pathology can be multilevel, irregularly shaped, and dynamic, minimal luminal area (MLA) may not provide the most comprehensive description diagnostic metric. Our aim was to examine utilization of computational fluid dynamics (CFD) purpose defining stenosis using an ovine model tissue-engineered tracheal graft (TETG) implantation.Animal research...

10.1002/lary.27233 article EN The Laryngoscope 2018-05-14
Coming Soon ...